Open access
101
Views
7
CrossRef citations to date
0
Altmetric
Original Research
A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective
Magdolna Barra1 Evidera, Budapest, Hungary
, Edit Remák1 Evidera, Budapest, Hungary
, Dong Dong Liu2 Health Economics & Outcomes Research, Pfizer Investment Co., Ltd., Beijing, China
, Li Xie2 Health Economics & Outcomes Research, Pfizer Investment Co., Ltd., Beijing, China
, Lucy Abraham3 Health Economics & Outcomes Research, Pfizer Ltd, Tadworth, UK, [email protected]Correspondence[email protected]
& Alesia B Sadosky4 Health Economics & Outcomes Research, Pfizer Inc, New York, NY, USA
Pages 169-177
|
Published online: 22 Feb 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.